MYC and neoplasm: As a group, these synthetic lethal inhibitors seem to promote tumor cell demise either by altering the balance of Myc protein needed for tumor cell viability or by capitalizing upon Myc's tendency to promote aneuploidy [13, 29] by compromising the transformed cell's ability to faithfully partition its abnormal chromosome complement.